Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Key Market Size Shifts in the Enzyme Replacement Therapy Market: A Historical Perspective and beyond
The market size of enzyme replacement therapy has seen considerable growth in the later years. Its expansion is expected to continue from $11.58 billion in 2024 to reach $12.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%.
The increase during the historical period can be linked to factors such as the pioneering approval of treatments, enhanced understanding of diseases, successful clinical outcomes, support from regulatory bodies, and incentives, along with the rise in early therapeutic discoveries.
Expectations are high for the enzyme replacement therapy market to experience significant expansion in the coming years. The market is forecasted to rise to $17.48 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.0%.
The projected growth within this period can be ascribed to factors like the increasing access of patients to healthcare, customized treatments, advancements in personalized medicine, alterations in regulatory frameworks, and heightened awareness within patient populations. The forecasted timeframe will likely witness trends like the incorporation of digital health, concentration on patient-oriented solutions, flourishing biomarker research, and the implementation of methods focused on precision medicine.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Driving the Continued Growth of the Global Enzyme Replacement Therapy Market?
The enzyme replacement therapy market is expected to be boosted by the increasing instances of very uncommon, continuous, and genetic disorders. Chronic disease is a long-term health condition lasting at least three months and can progressively worsen over time.
Such diseases are more frequently found among the elderly and can hypothetically be managed but not entirely cured.
Taking an example, in July 2024, the US-based American Lung Association, a non-profit organization, announced that 44.2 million Americans, or 13.5% of the population, were professionally diagnosed with asthma in 2022.
This was an increase from the 12.9% figure reported in 2021. Thus, the growing occurrence of very uncommon, continuous, and genetic diseases is anticipated to fuel the expansion of the enzyme replacement therapy market.
Top Revenue-Generating Segments in the Enzyme Replacement Therapy Market
The enzyme replacement therapy market covered in this report is segmented –
1) By Enzyme Type: Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types
2) By Route Of Administration: Oral, Parenteral
3) By Application: Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications
4) By End-Users: Hospitals, Infusion Centers, Other End-Users
Subsegments:
1) By Agalsidase Alfa: Fabry Disease Treatment
2) By Agalsidase Beta: Fabry Disease Treatment
3) By Galsulfase: Mucopolysaccharidosis VI (MPS VI) Treatment
4) By Other Enzyme Types: Alglucosidase Alfa, Idursulfase, Velaglucerase Alfa
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Trends Will Guide the Development Path of the Enzyme Replacement Therapy Industry?
The trend of gaining approval for products is becoming increasingly prevalent in the enzyme replacement therapy market. Several medications in this field by big players are receiving approval.
For instance, Lamzede (velmanase alfa), the first enzyme replacement therapy sanctioned for use in the United States for non-central neurological indications of alpha-mannosidosis, was approved by the US-based Food and Drug Administration, a federal division of the Health Department, in February 2023. Alpha-mannosidosis is a rare genetic disorder characterized by the lack of the alpha-mannosidase enzyme in the body.
Lamzede is beneficial for patients as it functions similarly to the alpha-mannosidase enzyme in the body, restoring normal cell function. Patients receive a 10mg injection of Lamzede once a week.
How Are Different Regions Contributing to the Enzyme Replacement Therapy Market’s Growth?
North America was the largest region in the enzyme replacement therapy market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Firms Are Setting the Benchmark in the Global Enzyme Replacement Therapy Market?
Major companies operating in the enzyme replacement therapy market include Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Johnson & Johnson Services Inc., Alexion Pharmaceuticals Inc., Recordati Rare Diseases Inc., Sangamo Therapeutics Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co.
Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=10512
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
